Actuate Therapeutics, Inc. Common stock ACTU

Set alert

Price alert · ACTU

All alert types
0.34 USD -0.04 -9.68%

At close

0.34 0.00 -0.03%

Pre-market · Nov 2, 4:00 AM ET

Bid
0.34 × 2
Ask
0.35 × 2
0.33 Day range 0.385
0.33 52-week range 7.90
YTD
-94.52%
1 year
-94.91%
Open
0.38
Prev close
0.371
Mkt cap
18.43M
Vol
489.47K
Avg vol
413.88K
EPS
-0.87
P/E
0.00
Div yield
0.00%
More statistics
Low
0.33
High
0.385
Forward P/E
0.00
Beta
0.00
Short ratio
0.49
Inst. own
53.05%
Dividend
0.00
Ex-div date
50-d avg
8.35
200-d avg
8.07
1y target
0.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for ACTU has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-56.09 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -5.8×
FY 2022: -6.4×FY 2023: -5.2×FY 2024: -2.4×FY 2025: -5.8×
FY 2022 5y median -5.5× FY 2025
P/S 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 16.2×
FY 2022: 8.7×FY 2023: -1.3×FY 2024: 1491×FY 2025: 16.2×
FY 2022 5y median 12.5× FY 2025
P/FCF -6.7×
FY 2022: -7.3×FY 2023: -6.0×FY 2024: -7.1×FY 2025: -6.7×
FY 2022 5y median -6.9× FY 2025
EV/EBITDA -5.2×
FY 2022: 1720×FY 2023: 464×FY 2024: -68.4×FY 2025: -5.2×
FY 2022 5y median 229× FY 2025
EV/Sales 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -14.9%
FY 2022: -13.7%FY 2023: -16.7%FY 2024: -14.1%FY 2025: -14.9%
FY 2022 5y median -14.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -280.5%
FY 2022: -135.9%FY 2023: 24.8%FY 2024: -26189.1%FY 2025: -280.5%
FY 2022 5y median -208.2% FY 2025
ROIC -270.1%
FY 2022: -125.2%FY 2023: 636.3%FY 2024: -4876.6%FY 2025: -270.1%
FY 2022 5y median -197.6% FY 2025
ROA -158.4%
FY 2022: -98.4%FY 2023: -826.0%FY 2024: -292.8%FY 2025: -158.4%
FY 2022 5y median -225.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 FY 2025
Operating Income 10.6%
FY 2022: 0.0%FY 2023: -23.6%FY 2024: -0.7%FY 2025: 10.6%
FY 2022 FY 2025
EPS (diluted) 67.5%
FY 2022: 0.0%FY 2023: -23.1%FY 2024: -97.6%FY 2025: 67.5%
FY 2022 FY 2025
Free Cash Flow 12.1%
FY 2022: 0.0%FY 2023: -21.5%FY 2024: -1.0%FY 2025: 12.1%
FY 2022 FY 2025

Financial Health

Current Ratio 2.4×
FY 2022: 4.7×FY 2023: 0.4×FY 2024: 1.0×FY 2025: 2.4×
FY 2022 5y median 1.7× FY 2025
Quick Ratio 2.4×
FY 2022: 4.7×FY 2023: 0.4×FY 2024: 1.0×FY 2025: 2.4×
FY 2022 5y median 1.7× FY 2025
Debt / Equity 0.1×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2022: -315×FY 2023: -10.8×FY 2024: 4.0×FY 2025: 0.6×
FY 2022 5y median -5.1× FY 2025
Interest Coverage -1111×
FY 2022: -1247×FY 2023: -572×FY 2024: 1344×FY 2025: -1111×
FY 2022 5y median -842× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31